Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | APAF1 | O14727 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.52 |
| ▸ | FDPS | P14324 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PON1 | P27169 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL2229889 | 0.98 | SMN1; SMN2 (0.55) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| Iodide SCHEMBL12469710 | 0.98 | SMN1; SMN2 (0.50) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| Hydrochloric Acid SCHEMBL6114821 | 0.98 | SMN1; SMN2 (0.50) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL26695497 | 0.90 | SMN1; SMN2 (0.51) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL2527601 | 0.88 | SMN1; SMN2 (0.58) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL3118979 | 0.88 | SMN1; SMN2 (0.42) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL2525893 | 0.86 | SMN1; SMN2 (0.61) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| Hydrochloric Acid SCHEMBL6115353 | 0.86 | SMN1; SMN2 (0.56) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL16674008 | 0.85 | SMN1; SMN2 (0.53) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B | |
| SCHEMBL17706398 | 0.85 | SMN1; SMN2 (0.46) | SMN1; SMN2MEN1APAF1NPC1PLA2G1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3103156-B1 | GELATED IONIC LIQUID FILM-COATED SURFACES AND USES THEREOF | GELION TECH PTY LTD (AU) | 2019-06-12 | — | — | EP | claimed |
| US-20190097273-A1 | GELATED IONIC LIQUID FILM-COATED SURFACES AND USES THEREOF | GELION TECH PTY LTD (AU) | 2019-03-28 | — | — | US | claimed |
| US-10122049-B2 | Gelated ionic liquid film-coated surfaces and uses thereof | GELION TECHNOLOGIES PTY LTD (AU) | 2018-11-06 | — | — | US | claimed |
| EP-3103156-A1 | GELATED IONIC LIQUID FILM-COATED SURFACES AND USES THEREOF | Gelion Technologies PTY LTD (AU) | 2016-12-14 | — | — | EP | claimed |
| US-20160351969-A1 | GELATED IONIC LIQUID FILM-COATED SURFACES AND USES THEREOF | GELION TECHNOLOGIES PTY LTD (AU) | 2016-12-01 | — | — | US | claimed |
| EP-1640654-B1 | Ionic liquid based mixtures for gas storage and delivery | AIR PROD & CHEM (US) | 2016-10-19 | — | — | EP | claimed |
| US-9058935-B2 | Compounds containing alkyl-cyano-borate or alkyl-cyano-fluoroborate anions | MERC PATENT GMBH (DE) | 2015-06-16 | — | — | US | claimed |
| EP-2526105-B1 | ELECTROLYTE FORMULATIONS | MERCK PATENT GMBH (DE) | 2015-06-03 | — | — | EP | claimed |
| US-8921589-B2 | Electrolyte formulations | MERCK PATENT GMBH (DE) | 2014-12-30 | — | — | US | claimed |
| US-8864883-B2 | Surface treatments for dessicant media in a water recovery device | Z124 (KY) | 2014-10-21 | — | — | US | claimed |
| US-20120318360-A1 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | claimed |
| US-20120309982-A1 | ELECTROLYTE FORMULATIONS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-12-06 | — | — | US | claimed |
| US-20120204717-A1 | APPARATUS AND METHOD FOR REMOVING CO2 FROM A PRODUCTION PLANT DISCHARGE | MUNTERS CORPORATION (US) | 2012-08-16 | — | — | US | claimed |
| WO-2012109547-A1 | APPARATUS AND METHOD FOR REMOVING CO2 FROM A PRODUCTION PLANT DISCHARGE | MUNTERS CORPORATION (US) | 2012-08-16 | — | — | WO | claimed |
| US-20110247494-A1 | LIQUID SORBANT, METHOD OF USING A LIQUID SORBANT, AND DEVICE FOR SORBING A GAS | VTU Holding GmbH. (AT) | 2011-10-13 | — | — | US | claimed |
| WO-2011085965-A1 | ELECTROLYTE FORMULATIONS | MERCK PATENT GMBH (DE) | 2011-07-21 | — | — | WO | claimed |
| US-7563308-B2 | Ionic liquid based mixtures for gas storage and delivery | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2009-07-21 | — | — | US | claimed |
| EP-1640654-A1 | Ionic liquid based mixtures for gas storage and delivery | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2006-03-29 | — | — | EP | claimed |
| US-20060060817-A1 | Ionic liquid based mixtures for gas storage and delivery | VERSUM MATERIALS US, LLC | 2006-03-23 | — | — | US | claimed |
| US-20060060818-A1 | Ionic liquid based mixtures for gas storage and delivery | VERSUM MATERIALS US, LLC | 2006-03-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120318360-A1 | Electrolyte Formulations | NHERF1, HCN4, DDT | SMN1; SMN2 4519/4885MEN1 1923/4885APAF1 4563/4885 |
| US-20120309982-A1 | ELECTROLYTE FORMULATIONS | SLC9A5, NHERF1, AFF1 | SMN1; SMN2 4623/4885MEN1 2076/4885APAF1 1920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.